(NASDAQ: OMER) Omeros's forecast annual revenue growth rate of 103.51% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 29.73%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.59%.
Omeros's revenue in 2026 is $38,422,000.On average, 5 Wall Street analysts forecast OMER's revenue for 2026 to be $9,414,100,496, with the lowest OMER revenue forecast at $7,314,115,449, and the highest OMER revenue forecast at $11,485,130,217. On average, 5 Wall Street analysts forecast OMER's revenue for 2027 to be $16,340,938,454, with the lowest OMER revenue forecast at $13,564,122,652, and the highest OMER revenue forecast at $20,844,939,475.
In 2028, OMER is forecast to generate $23,477,702,528 in revenue, with the lowest revenue forecast at $16,607,327,457 and the highest revenue forecast at $28,654,914,889.